Innovation rooted in tradition. We are entering this space now determined to work with physicians, pharmacists and researchers to expand the clinical evidence base for cannabis therapy and develop the products that meet patients’ needs.
Cultivation in Portugal. In our Portuguese facility, we breed and cultivate selected cannabis genetics that produce exceptional outcomes in extraction and further pharmaceutical manufacturing.
GMP Manufacturing in Germany. Our products are manufactured in a remarkable facility in the center of Germany’s pharmaceutical manufacturing hub. Our exclusive partner has designed and constructed this state-of-the-art manufacturing site exclusively for the production of cannabis-based medicines.
Highest Quality Standard. This is the guarantee for our exceptional product quality.
Clinical Program. Avextra collaborates with researchers and healthcare professionals to collect and aggregate real world patient data and RCTs to inform and support regulatory filings.
Cannabis-based medicines that combine innovation and tradition. Avextra is a young company with deep roots in plant-based medicines and the science of botanical extraction. Our focus is on innovation in research and in phyto-pharmaceutical manufacturing.